|
|||||
|
|
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 |
|
| Authors: | Andries Koen Azijn Hilde Thielemans Theo Ludovici Donald Kukla Michael Heeres Jan Janssen Paul De Corte Bart Vingerhoets Johan Pauwels Rudi de Béthune Marie-Pierre |
| Affiliation: | Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |